Regen BioPharma Inc (RGBP)

[cvinvestor]

Schuller, I'm not against all bonuses. Not all bonuses are fair, should be accepted blindly by shareholders or are good for a company just because they are commonplace. I have given my reasons in the past why I am against these bonuses of 10 M shares each given to Koos, Cavens and Lander.

- 1st, they were not part of their written contracts (this we know from Cavens hiring and listing of milestone shares - not there). If they were part of Koos, Cavens contract, then they should have been issued immediately as milestone shares, but they weren't, they were issued two Qtrs after the FDA approval of HemaX and the PR was clear on "the reason" for the bonuses.

-2nd, the shares issued were preferred shares when common shares were trading at .10/share and preferred are objectively more valuable. So at a minimum, they gave themselves a million dollars in value each at a time when the company is struggling for funding - something Cavens and Lander both were specifically hired to do as part of their job. But even though outside of the friends and family share giving, we know nothing of Cavens raising any money and there is no funds raised yet by Lander in any PR, but hell, let's give him a million dollars in shares because he came on board. Or were they shares to keep him quiet? Lander's contract is clear on milestone shares and he is to receive bonuses when a product is at stage 2 of a human trial or he brings in millions of dollars of funding for the company from new sources. Now that we know they've hire OCP to do that basically because Cavens and Lander have not, what's the merit for Lander to get $1M?

-3rd, this is purely reading between the lines unlike 1 and 2, but because of 1 and 2 above, these bonus shares smell to me and when management gives themselves bonus shares 6 months after the reason given for those shares, it doesn't jive with me. My reading: Koos, Cavens and Lander realized they weren't going to succeed in bringing in the funds necessary to carry HemaX forward on their own, so they discussed getting an outside firm and moving in the current direction - licensing or selling off parts of the company or the company as a whole (Yes, that's in the contract with OCP to the tune of a minimum $250,000 payment to OCP if it occurs). So, in order not to risk getting into an agreement with larger entities where they might not be able to give themselves bonuses later to their likings, they made up the reason to give themselves a big piece of pie now before entering into any agreements, even though those shares were not milestone shares.

And they did it after promising shareholders in January of seeking non-dilutive funding and ending the discount share programs. So giving themselves 30 million shares 3 months later and 4 months after HemaX approval and including Lander who I do not see as being critical to that achievement doesn't go over well to me as a justified and company enhancing aspect seen by others and other companies as justified within a well managed company.


Also, just to note, the 30 million plus angel shares have not been out for almost 2 years. They have not been released to trade in full for even one year yet. Issued mainly between Jan 2015 and Mar 2015 with a six month restriction, they were not fully tradeable until Sept 2015. So we are 9 months after the fact with 30 million common clearly not traded in that time. Let's hope those that hold them are greedy and won't sell under a $1.00, but that's a Las Vegas bet.

Let's hope OCP can really leverage the science to strike deals that bring in the funds to carry the products forward and really add value to the company.

The fact that they have a $10,000/month retainer hopefully means deals are anticipated and likely to happen in the coming months or sooner. Most likely in my mind is the licensing of HemaX in light of the Mexican trials.

I'm hoping for a $1 share price, but actually at this point would be delighted to hit .50 before end of year.

I'm not sure why you are so hung up on the bonuses, they are commonplace in every business at every level.

I'm not in the prediction business but I believe the stock price of Regen will be at a whole other level by the end of June and give people a chance to exit if they want. Even Fuzzy can prepay for his flowers.

RGBP common has had almost two years to bleed out shares from the Angles. RGBPP not that long which explains the numerous high volume days of late as time is running out.

Believe me we're close.